Risk stratified monitoring for methotrexate toxicity in immune mediated inflammatory diseases: prognostic model development and validation using primary care data from the UK.

Nakafero, G. orcid.org/0000-0002-3859-7354, Grainge, M.J., Williams, H.C. et al. (9 more authors) (2023) Risk stratified monitoring for methotrexate toxicity in immune mediated inflammatory diseases: prognostic model development and validation using primary care data from the UK. BMJ, 381. e074678. ISSN 0959-8138

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2023, BMJ Publishing Group Ltd. This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/.

Dates:
  • Published: 30 May 2023
  • Published (online): 30 May 2023
  • Accepted: 21 April 2023
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield) > ScHARR - Sheffield Centre for Health and Related Research
Depositing User: Symplectic Sheffield
Date Deposited: 08 Jun 2023 14:55
Last Modified: 08 Jun 2023 14:55
Status: Published
Publisher: BMJ
Refereed: Yes
Identification Number: 10.1136/bmj-2022-074678
Related URLs:
Open Archives Initiative ID (OAI ID):

Download

Export

Statistics